Clinical Trials Logo

Stage IIA Pancreatic Cancer clinical trials

View clinical trials related to Stage IIA Pancreatic Cancer.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02414100 Withdrawn - Clinical trials for Pancreatic Ductal Adenocarcinoma

Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy

Start date: December 12, 2013
Phase: N/A
Study type: Observational

This pilot research trial studies patient derived cancer cell lines in identifying molecular changes in patients with previously untreated pancreatic cancer and are receiving gemcitabine hydrochloride-based chemotherapy. Cell lines refer to samples taken from the patient's tumor to grow for many months or years in a laboratory, and can therefore be studied scientifically. Studying cell lines in the laboratory may help doctors understand the genetic changes that occur to the tumor during chemotherapy that allows the tumor to resist or grow despite treatment.

NCT ID: NCT01954732 Withdrawn - Clinical trials for Stage IIB Pancreatic Cancer

Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery

Start date: January 2014
Phase: Phase 1
Study type: Interventional

This randomized clinical trial studies metformin hydrochloride in treating patients with pancreatic cancer that can be removed by surgery. Metformin hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.